Literature DB >> 27826577

A rare presentation of acute heart failure secondary to aggressive uterine leiomyosarcoma metastatic to the myocardium initially diagnosed as hypertrophic obstructive cardiomyopathy.

Michael Karass1, Pratik Mondal1, Mohammad Alkayem2, Amole Ojo3, Wilbert S Aronow3, Carmelo Puccio2.   

Abstract

Uterine sarcoma is the cause of 3-9% of all uterine malignant neoplasms and has a 2-fold higher incidence in black women as compared to white women. Cellular atypia and abundant mitoses (≥10 per 10 high power fields) as seen in this patient are associated with an increased risk for metastases. Metastases to the heart are infrequently reported with a handful of cases in the literature. We present a case of a 51-year-old woman with aggressively metastatic uterine leiomyosarcoma causing acute heart failure 4 months after initial presentation.

Entities:  

Keywords:  Uterine leiomyosarcoma; heart failure; myocardium

Year:  2016        PMID: 27826577      PMCID: PMC5075842          DOI: 10.21037/atm.2016.09.34

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  22 in total

1.  Usefulness of 18-fluorodeoxyglucose positron emission tomography in the evaluation of tumor cardiac thrombus from renal cell carcinoma.

Authors:  José R García; Marc Simo; Marina Huguet; Montserrat Ysamat; Francisco Lomeña
Journal:  Clin Transl Oncol       Date:  2006-02       Impact factor: 3.405

2.  Right atrial metastasis of uterine leiomyosarcoma causing obstructive shock.

Authors:  S K A Nguyen; F Wong
Journal:  Curr Oncol       Date:  2012-08       Impact factor: 3.677

Review 3.  Diagnosis and treatment of sarcoma of the uterus. A review.

Authors:  Claes G Tropé; Vera M Abeler; Gunnar B Kristensen
Journal:  Acta Oncol       Date:  2012-07       Impact factor: 4.089

4.  Inherited susceptibility to uterine leiomyomas and renal cell cancer.

Authors:  V Launonen; O Vierimaa; M Kiuru; J Isola; S Roth; E Pukkala; P Sistonen; R Herva; L A Aaltonen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

Review 5.  Unusual primary tumors of the heart.

Authors:  T J Vander Salm
Journal:  Semin Thorac Cardiovasc Surg       Date:  2000-04

Review 6.  Distant Metastases in Uterine Leiomyosarcomas: The Wide Variety of Body Sites and Time Intervals to Metastatic Relapse.

Authors:  Carla Bartosch; Mariana Afonso; Ana S Pires-Luís; Ana Galaghar; Marcos Guimarães; Luís Antunes; José M Lopes
Journal:  Int J Gynecol Pathol       Date:  2017-01       Impact factor: 2.762

7.  Cardiac metastasis from uterine leiomyosarcoma.

Authors:  F Moreno Antón; A Casado Herraez; J Puente Vázquez; R Gómez Díaz; P Aragoncillo; E Díaz-Rubio García
Journal:  Clin Transl Oncol       Date:  2006-05       Impact factor: 3.405

8.  Detection of cardiac myxoma by F-18 FDG PET.

Authors:  D Agostini; G Babatasi; F Galateau; G Grollier; J C Potier; G Bouvard
Journal:  Clin Nucl Med       Date:  1999-03       Impact factor: 7.794

9.  Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases.

Authors:  S W Bell; R L Kempson; M R Hendrickson
Journal:  Am J Surg Pathol       Date:  1994-06       Impact factor: 6.394

10.  Diagnosis of heart tumours by transoesophageal echocardiography: a multicentre study in 154 patients. European Cooperative Study Group.

Authors:  R Engberding; W G Daniel; R Erbel; W Kasper; C Lestuzzi; J M Curtius; G R Sutherland; H Lambertz; A von Hehn; J P Lesbre
Journal:  Eur Heart J       Date:  1993-09       Impact factor: 29.983

View more
  2 in total

1.  Multimodality Cardiac Imaging Assessment of a Large Metastatic Pericardial Leiomyosarcoma.

Authors:  Apichaya Sripariwuth; Bo Xu; Huang Steve Shih-Lin; Ryan S Berry; Sudish Murthy; Gosta Pettersson; Christine Jellis
Journal:  CASE (Phila)       Date:  2018-06-28

2.  Right ventricular outflow tract obstruction due to a leiomyosarcoma.

Authors:  Nicholas Suraci; Jason Hoyos; Diego Baruqui; Orlando Santana
Journal:  Ann Card Anaesth       Date:  2020 Jul-Sep
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.